Cancer-associated histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation

Authors

Benjamin A Nacev, University of Pittsburgh
Benjamin A Garcia, Washington University School of Medicine in St. Louis
et al.

Journal

Nature Communications

Publication Date

6-17-2024

Volume

15

Issue

1

First Page

5155

Document Type

Open Access Publication

DOI

10.1038/s41467-024-49486-5

Rights and Permissions

Nacev, B.A., Dabas, Y., Paul, M.R. et al. Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation. Nat Commun 15, 5155 (2024). https://doi.org/10.1038/s41467-024-49486-5 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Nacev, Benjamin A; Garcia, Benjamin A; and et al., "Cancer-associated histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation." Nature Communications. 15, 1. 5155 (2024).
https://digitalcommons.wustl.edu/oa_4/4003

Additional Links

Supplemental material is available for this article at publisher site.